News

Do doctors still trust J&J? (Morning Read)

Read current medical news from today, including: a quick survey indicates doctors no longer trust J & J, Tufts nurses strike vote approved, big funding for new cancer treatments, OrbiMed Advisors take $2w03 million to Israel, and doctors treat themselves a little bit differently than everyone else.

Current medical news and unique business news for anyone who cares about the healthcare industry.

Losing faith in J&J. Good news: 53 percent of physicians in an informal poll trust Johnson & Johnson more than ever. Bad news: the fact 47 percent of physicians distrust J&J is amazingly high number.

However, the response does suggest that Johnson & Johnson has a lot of work to do, not only with regulators, investors and consumers, but also the one group that has a huge influence on the success of its prescription and surgical products, as well as its prestige. The findings hint that some doctors may think twice about the reliability of Johnson & Johnson products, in general. And winning them back will take time and, possibly, expense. As Maris notes, the recalls may have a lasting impact.

Pharma companies are big jerks (before Phase 3). So is it true? “The default assumption today is that if you need a pharma company to step into your shoes at any point prior to Phase 3, it’s almost guaranteed that you’ll get a crappy deal. So why would any biotech investor or biotech executive want to beat their head against the wall?”

Big bet on cancer. Cancer therapy company Blueprint Medicines will get $40 million from Third Rock Ventures.

Tufts nurses strike vote coming. Nurses at Tufts Medical Center will vote Thursday whether to hold a one-day nursing strike. The yes vote would allow union leaders to call a one-day strike, which would happen 10 days after union leaders called for the strike.

OrbiMed to Israel. OrbiMed Advisors has raised $203 million to back 15 to 20 Israeli biomedical startups.

That’s (not) comforting. Doctors choose treatment options for themselves they would not suggest for their patients. “”The bottom line of the study is, those tradeoffs feel different if you are the decision maker vs. the advice giver,” Duke University Dr. Peter A. Ubel said.

Topics